• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    FitLife Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    12/16/24 8:00:21 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email
    ftlf20241212_8k.htm
    false 0001374328 0001374328 2024-12-16 2024-12-16
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549 
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of report (Date of earliest event reported): December 16, 2024
     
    Commission File Number: 000-52369
     
    FitLife Brands, Inc.
    (Exact name of registrant as specified in its charter.)
     
    Nevada
    20-3464383
    (State or other jurisdiction of incorporation
    or organization)
    (IRS Employer Identification No.)
     
    5214 S. 136th Street, Omaha, Nebraska 68137
    (Address of principal executive offices)
     
    402-884-1894
    (Registrant's Telephone number)
     
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of exchange on which registered
    Common Stock, par value $0.01 per share
    FTLF
    Nasdaq Capital Market
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 7.01
    Regulation FD Disclosure.
     
    On December 16, 2024, FitLife Brands, Inc. (the “Company”) began utilizing a new corporate presentation (the “Corporate Presentation”) for business purposes. A copy of the Corporate Presentation is attached to this Current Report on Form 8-K as Exhibit 99.1.
     
    The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall any exhibit filed herewith be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
     
    Item 9.01
    Financial Statements and Exhibits.
     
    (d) Exhibits Index
     
    Exhibit No.
     
    Description
    99.1
     
    Corporate Presentation dated December 16, 2024
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
     
    FitLife Brands, Inc.
         
    Date: December 16, 2024
    By:
    /s/ Dayton Judd
       
    Dayton Judd
       
    Chief Executive Officer
     
     
    Get the next $FTLF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    SEC Filings

    See more
    • FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      5/15/25 8:00:17 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 10-Q filed by FitLife Brands Inc.

      10-Q - FITLIFE BRANDS, INC. (0001374328) (Filer)

      5/15/25 7:30:49 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form 10-K/A filed by FitLife Brands Inc.

      10-K/A - FITLIFE BRANDS, INC. (0001374328) (Filer)

      4/28/25 6:43:29 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/2/25 8:01:06 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care